49 related articles for article (PubMed ID: 28108270)
1. Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
Burroughs LM; O'Donnell PV; Sandmaier BM; Storer BE; Luznik L; Symons HJ; Jones RJ; Ambinder RF; Maris MB; Blume KG; Niederwieser DW; Bruno B; Maziarz RT; Pulsipher MA; Petersen FB; Storb R; Fuchs EJ; Maloney DG
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1279-87. PubMed ID: 18940683
[TBL] [Abstract][Full Text] [Related]
2. Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide.
Shah NN; Freeman AF; Su H; Cole K; Parta M; Moutsopoulos NM; Baris S; Karakoc-Aydiner E; Hughes TE; Kong HH; Holland SM; Hickstein DD
Biol Blood Marrow Transplant; 2017 Jun; 23(6):980-990. PubMed ID: 28288951
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome.
Armand P; Kim HT; Ho VT; Cutler CS; Koreth J; Antin JH; LaCasce AS; Jacobsen ED; Fisher DC; Brown JR; Canellos GP; Freedman AS; Soiffer RJ; Alyea EP
Biol Blood Marrow Transplant; 2008 Apr; 14(4):418-25. PubMed ID: 18342784
[TBL] [Abstract][Full Text] [Related]
4. HLA-haploidentical T-cell receptor αβT/B-cell-depleted stem cell transplantation for Fanconi anemia.
Iguchi A; Uchiyama T; Fujimori K; Gocho Y; Sakaguchi H; Deguchi T; Tomizawa D; Imadome KI; Onodera M; Matsumoto K
Int J Hematol; 2024 Mar; 119(3):334-337. PubMed ID: 38227075
[TBL] [Abstract][Full Text] [Related]
5. Peritransplant glucocorticoids redistribute donor T cells to the bone marrow and prevent relapse after haploidentical SCT.
Inoue T; Koyama M; Kaida K; Ikegame K; Ensbey KS; Samson L; Takahashi S; Zhang P; Minnie SA; Maruyama S; Ishii S; Daimon T; Fukuda T; Nakamae H; Ara T; Maruyama Y; Ishiyama K; Ichinohe T; Atsuta Y; Blazar BR; Furlan SN; Ogawa H; Hill GR
JCI Insight; 2021 Nov; 6(22):. PubMed ID: 34637399
[TBL] [Abstract][Full Text] [Related]
6. Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
Fürst S; Bernit E; Legrand F; Granata A; Harbi S; Devillier R; Maisano V; Bouchacourt B; Pagliardini T; Mokart D; Lemarié C; Calmels B; Picard C; Basire A; Andersson BS; Blaise D
Bone Marrow Transplant; 2024 Mar; ():. PubMed ID: 38486114
[TBL] [Abstract][Full Text] [Related]
7. The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.
Klyuchnikov E; Bacher U; Kröger N; Kazantsev I; Zabelina T; Ayuk F; Zander AR
Adv Hematol; 2011; 2011():974658. PubMed ID: 20981158
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic transplantation after immunotherapy for relapsed/refractory non-Hodgkin lymphoma: a comparison with a historical cohort.
Mariotti J; Zucchinetti C; Giordano L; De Philippis C; Mannina D; Sarina B; Taurino D; Carbon R; Santoro A; Bramanti S
Cytotherapy; 2024 May; ():. PubMed ID: 38775776
[TBL] [Abstract][Full Text] [Related]
9. Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Martínez C; Gayoso J; Canals C; Finel H; Peggs K; Dominietto A; Castagna L; Afanasyev B; Robinson S; Blaise D; Corradini P; Itälä-Remes M; Bermúdez A; Forcade E; Russo D; Potter M; McQuaker G; Yakoub-Agha I; Scheid C; Bloor A; Montoto S; Dreger P; Sureda A;
J Clin Oncol; 2017 Oct; 35(30):3425-3432. PubMed ID: 28846465
[TBL] [Abstract][Full Text] [Related]
10. Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.
Bashey A; Zhang MJ; McCurdy SR; St Martin A; Argall T; Anasetti C; Ciurea SO; Fasan O; Gaballa S; Hamadani M; Munshi P; Al Malki MM; Nakamura R; O'Donnell PV; Perales MA; Raj K; Romee R; Rowley S; Rocha V; Salit RB; Solh M; Soiffer RJ; Fuchs EJ; Eapen M
J Clin Oncol; 2017 Sep; 35(26):3002-3009. PubMed ID: 28644773
[TBL] [Abstract][Full Text] [Related]
11. Relapse of Hodgkin lymphoma after autologous transplantation: Time to rethink treatment?
Jethava Y; Guru Murthy GS; Hamadani M
Hematol Oncol Stem Cell Ther; 2017 Jun; 10(2):47-56. PubMed ID: 28183681
[TBL] [Abstract][Full Text] [Related]
12. Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability.
Xavier FD; Farias DLC; Neto AEH; Ribeiro GN; Araujo MAS; Carneiro TX; Baiocchi OCCG
Oncotarget; 2023 Dec; 14():977-994. PubMed ID: 38085126
[TBL] [Abstract][Full Text] [Related]
13. Haploidentical Stem Cell Transplantation With Post-Transplantation Cyclophosphamide for Aggressive Lymphomas: How Far Have We Come and Where Are We Going?
Patel DA
World J Oncol; 2019 Feb; 10(1):1-9. PubMed ID: 30834047
[TBL] [Abstract][Full Text] [Related]
14. Human Leukocyte Antigen-Haploidentical Transplantation for Relapsed/Refractory Hodgkin Lymphoma: A Multicenter Analysis.
Lacerda MP; Arrais Rodrigues C; Pereira AD; Novis Y; Fonseca M; Silva RL; Macedo MCMA; Hamerschlak N; Esteves I; Schmidt Filho J; Nascimento MM; Rocha V
Biol Blood Marrow Transplant; 2017 Apr; 23(4):705-707. PubMed ID: 28108270
[TBL] [Abstract][Full Text] [Related]
15. Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience.
Gayoso J; Balsalobre P; Pascual MJ; Castilla-Llorente C; López-Corral L; Kwon M; Serrano D; Piñana JL; Herrera P; Ferrá C; Pascual C; Heras I; Montesinos P; Zabalza A; Bento L; Figuera A; Buño I; Díez-Martín JL
Bone Marrow Transplant; 2016 Oct; 51(10):1307-1312. PubMed ID: 27159177
[TBL] [Abstract][Full Text] [Related]
16. T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
Mariotti J; Devillier R; Bramanti S; Sarina B; Furst S; Granata A; Faucher C; Harbi S; Morabito L; Chabannon C; Carlo-Stella C; Bouabdallah R; Santoro A; Blaise D; Castagna L
Biol Blood Marrow Transplant; 2018 Mar; 24(3):627-632. PubMed ID: 29197681
[TBL] [Abstract][Full Text] [Related]
17. Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma.
Illhardt T; Toporski J; Feuchtinger T; Turkiewicz D; Teltschik HM; Ebinger M; Schwarze CP; Holzer U; Lode HN; Albert MH; Gruhn B; Urban C; Dykes JH; Teuffel O; Schumm M; Handgretinger R; Lang P
Biol Blood Marrow Transplant; 2018 May; 24(5):1005-1012. PubMed ID: 29307718
[TBL] [Abstract][Full Text] [Related]
18. [Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].
Nguyen S; Chalandon Y; Lemarie C; Simon S; Masson D; Dhedin N; Suarez F; Renaud B; Charbonnier A; Yafour N; François S; Duléry R; Blaise D; Yakoub-Agha I; Rubio MT
Bull Cancer; 2016 Nov; 103(11S):S229-S242. PubMed ID: 27842860
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
